JeremySugarmanMD

PubMed

• Post-trial responsibilities in pragmatic clinical trials: Fulfilling the promise of research to drive real-world change.
  Stephanie R Morain, P Pearl O'Rourke, Joseph Ali, Vasiliki Rahimzadeh, Devon K Check
  Learning Health Systems. 2024-07-01
• Potential corporate uses of polygenic indexes: Starting a conversation about the associated ethics and policy issues.
  Michelle N Meyer, Nicholas W Papageorge, Erik Parens, Alan Regenberg, Jeremy Sugarman
  American Journal of Human Genetics. 2024-05-02
• Patient Perspectives on Solid Organ Transplantation From Donors With Hepatitis C Viremia to Recipients Without Hepatitis C Viremia.
  Karen B Vanterpool, Kadiatou Diallo, Ellie Kim, Sarah E Van Pilsum Rasmussen, Morgan A Johnson
  Open Forum Infectious Diseases. 2024-03-01

Journal Articles

• Safety, Tolerability, and Pharmacokinetics of Long-Acting Injectable Cabotegravir in Low-Risk HIV-Uninfected Individuals: HPTN 077, a Phase 2a Randomized Controlled Trial  
  Susan H Eshleman, Joseph J Eron, Raphael J Landovitz, Myron S Cohen, Jeremy Sugarman, Mark A Marzinke, Craig W Hendrix, PLoS One
• Regional Differences Between People Who Inject Drugs in an HIV Prevention Trial Integrating Treatment and Prevention (HPTN 074): A Baseline Analysis  
  Jeremy Sugarman, Susan H Eshleman, Journal of the International AIDS Society
• Perceptions of HIV Cure Research Among People Living with HIV in Australia  
  Joseph D. Tucker, Jeremy Sugarman, J Sugarman, PLoS One